Industry Awaits Combination Guidance to Speed Product Approvals

Drug Industry Daily
KEYWORDS FDA / Guidances
A A

Industry officials and consultants say that upcoming FDA guidance is necessary to accelerate approvals of combination products because of lingering uncertainties about whether manufacturers must meet drug or device requirements.

To View This Article:

Login

Subscribe To Drug Industry Daily